STK33 Products
(serine/threonine Kinase 33 (STK33))
Categories
Serine/threonine protein kinase which phosphorylates VIME. May play a specific role in the dynamic behavior of the intermediate filament cytoskeleton by phosphorylation of VIME (By similarity).
antibodies-online.com stands for high-quality research products. Search, find and order tools with extensive validation data, images, references. Our scientific customer service is always at your disposal if you have any questions about the selection or application of our products.
Featured STK33 Categories
STK33 Antibodies
High quality antibodies with extensive validation data.
STK33 Proteins
Proteins for various applications incl. WB, ELISA, IF etc.
Recommended STK33 Antibodies
Product
Reactivity
Application
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Application
WB, ELISA, IF, IP
Validations
- (2)
- (8)
Cat. No.
ABIN566314
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IF, IP, RNAi
Validations
- (1)
- (7)
Cat. No.
ABIN566310
Quantity
100 μg
Datasheet
Datasheet
Reactivity
Human
Application
WB, ELISA, IP
Validations
- (2)
- (5)
Cat. No.
ABIN566312
Quantity
50 μg
Datasheet
Datasheet
Recommended STK33 ELISA Kits
Product
Reactivity
Analytical Method
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
Cat. No.
ABIN6232490
Quantity
96 tests
Datasheet
Datasheet
Recommended STK33 Proteins
Product
Reactivity
Source
Validations
Cat. No.
Quantity
Datasheet
Reactivity
Human
Source
Wheat germ
Validations
- (2)
Cat. No.
ABIN1321694
Quantity
10 μg
Datasheet
Datasheet
Reactivity
Human
Source
Insect Cells
Validations
Cat. No.
ABIN5509163
Quantity
10 μg
Datasheet
Datasheet
Reactivity
Human
Source
Tobacco (Nicotiana tabacum)
Validations
Cat. No.
ABIN3073473
Quantity
1 mg
Datasheet
Datasheet
Latest Publications for our STK33 products
: "Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33." in: The Journal of experimental medicine, Vol. 209, Issue 4, pp. 697-711, (2012) (PubMed).: "STK33 kinase activity is nonessential in KRAS-dependent cancer cells." in: Cancer research, Vol. 71, Issue 17, pp. 5818-26, (2011) (PubMed).
: "Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells." in: Cell, Vol. 137, Issue 5, pp. 821-34, (2009) (PubMed).
: "Phosphoinositide 3-kinase signalling pathways." in: Journal of cell science, Vol. 114, Issue Pt 8, pp. 1439-45, (2001) (PubMed).
: "Oncogenic kinase signalling." in: Nature, Vol. 411, Issue 6835, pp. 355-65, (2001) (PubMed).
: "The RET proto-oncogene in human cancers." in: Oncogene, Vol. 19, Issue 49, pp. 5590-7, (2000) (PubMed).
Synonyms and alternative names related to STK33
serine/threonine kinase 33 (STK33), serine/threonine kinase 33 (Stk33), 4921505G21Rik, AW061264Protein level used designations for STK33
- serine/threonine-protein kinase 33
You are here:
